Skip to content
10-K

Annual Report

SOLENO THERAPEUTICS INC

0001193125-26-071808

← back to feed
Filed
Feb 25, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 19, 2026 51.62M sh
Shares Diluted FY 2025 · Dec 31, 2025 52.38M sh
Shares Diluted FY 2025 · Dec 31, 2024 40.18M sh
Shares Diluted FY 2025 · Dec 31, 2023 16.49M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $100.15M
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Stock Repurchased FY 2025 · Dec 31, 2023 $0
Capex FY 2025 · Dec 31, 2025 $73K
Capex FY 2025 · Dec 31, 2024 $218K
Capex FY 2025 · Dec 31, 2023 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 $46.8M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$69.1M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$24.94M
Long Term Debt FY 2025 · Dec 31, 2025 $49.86M
Long Term Debt FY 2025 · Dec 31, 2024 $49.83M
Cash And Equivalents FY 2025 · Dec 31, 2025 $70.11M
Cash And Equivalents FY 2025 · Dec 31, 2024 $87.93M
Stockholders Equity FY 2025 · Dec 31, 2025 $450.12M
Stockholders Equity FY 2025 · Dec 31, 2024 $245.11M
Stockholders Equity FY 2025 · Dec 31, 2023 $157.51M
Stockholders Equity FY 2025 · Dec 31, 2022 $10.35M
Current Liabilities FY 2025 · Dec 31, 2025 $61.36M
Current Liabilities FY 2025 · Dec 31, 2024 $18.75M
Total Liabilities FY 2025 · Dec 31, 2025 $113.72M
Total Liabilities FY 2025 · Dec 31, 2024 $85.86M
Current Assets FY 2025 · Dec 31, 2025 $355.81M
Current Assets FY 2025 · Dec 31, 2024 $293.89M
Total Assets FY 2025 · Dec 31, 2025 $563.83M
Total Assets FY 2025 · Dec 31, 2024 $330.97M
Eps Diluted FY 2025 · Dec 31, 2025 $0.39
Eps Diluted FY 2025 · Dec 31, 2024 −$4.38
Eps Diluted FY 2025 · Dec 31, 2023 −$2.36
Eps Basic FY 2025 · Dec 31, 2025 $0.40
Eps Basic FY 2025 · Dec 31, 2024 −$4.38
Eps Basic FY 2025 · Dec 31, 2023 −$2.36
Sga Expense FY 2025 · Dec 31, 2025 $132.13M
Sga Expense FY 2025 · Dec 31, 2024 $105.86M
Sga Expense FY 2025 · Dec 31, 2023 $13.48M
Rd Expense FY 2025 · Dec 31, 2025 $40.63M
Rd Expense FY 2025 · Dec 31, 2024 $78.57M
Rd Expense FY 2025 · Dec 31, 2023 $25.19M
Net Income FY 2025 · Dec 31, 2025 $20.89M
Net Income FY 2025 · Dec 31, 2024 −$175.85M
Net Income FY 2025 · Dec 31, 2023 −$38.99M
Operating Income FY 2025 · Dec 31, 2025 $9.41M
Operating Income FY 2025 · Dec 31, 2024 −$187.67M
Operating Income FY 2025 · Dec 31, 2023 −$41.38M
Cost Of Revenue FY 2025 · Dec 31, 2025 $2.7M